RESPONSE BIOMEDICAL CORP Depreciation and Amortization

RESPONSE BIOMEDICAL CORP Depreciation and Amortization

RESPONSE BIOMEDICAL CORP reported Depreciation and Amortization of CAD 709.00 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.

Discontinued › Cash Flow › Operating Activities

us-gaap:DepreciationDepletionAndAmortization · last filed 2016-11-14

• RESPONSE BIOMEDICAL CORP depreciation, depletion and amortization for the quarter ending 2016-09-30 was 214.00K CAD, a 13.71% decline year-over-year.
• RESPONSE BIOMEDICAL CORP depreciation, depletion and amortization for the quarter ending 2016-06-30 was 246.00K CAD, a 2.38% decline year-over-year.
• RESPONSE BIOMEDICAL CORP depreciation, depletion and amortization for the quarter ending 2016-03-31 was 249.00K CAD, a 1.58% decline year-over-year.
• RESPONSE BIOMEDICAL CORP depreciation, depletion and amortization for the quarter ending 2015-12-31 was 250.00K CAD, a 0.40% decline year-over-year.
• RESPONSE BIOMEDICAL CORP depreciation, depletion and amortization for fiscal 2015 was 1.00M CAD, a 0.91% increase from fiscal 2014.
• RESPONSE BIOMEDICAL CORP depreciation, depletion and amortization for fiscal 2014 was 994.00K CAD, a 0.20% increase from fiscal 2013.
• RESPONSE BIOMEDICAL CORP depreciation, depletion and amortization for fiscal 2013 was 992.00K CAD, a 13.21% decline from fiscal 2012.
• RESPONSE BIOMEDICAL CORP depreciation, depletion and amortization for fiscal 2012 was 1.14M CAD, a 14.51% decline from fiscal 2011.